InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（2 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
2
T+90 胜率
100%
T+90 平均收益
+13.8%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the detailed record of transactions filed by Farkas Charles, 董事. Director active across 1 company, notably CONMED Corp. Cumulatively, 11 reports have been recorded. Breakdown: 1 buy · 2 sells. Total volume traded: €252k. History available since 1 June 2021. The latest transaction was disclosed on 2 June 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Farkas Charles
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
668 股0Common StockSEC:0000816956-26-000069:0
1,103 股@ US$53.53515.0% 占其流量Common StockSEC:0000816956-25-000042:0
479 股0Common StockSEC:0001127602-25-016762:0
1,000 股@ US$55.7017.1% 占其流量Common StockSEC:0001127602-25-016068:0
4,000 股@ US$56.94270.4% 占其流量Common StockSEC:0001127602-25-013471:0
1,000 股@ US$39.6412.5% 占其流量Common StockSEC:0001127602-24-023639:0
302 股0Common StockSEC:0001127602-24-017849:0
335 股0Common StockSEC:0001127602-23-017622:0
812 股0Common StockSEC:0001127602-22-016538:0
1,521 股0Common StockSEC:0001127602-21-018898:0
332 股Common StockSEC:0001127602-16-035487:0
标准退出：2016年4月3日 (T+90)
11 条申报中的 11 条
About Farkas Charles
Farkas Charles is Administrateur and Director at CONMED Corp. He has 11 filings, and across the sampled recent filings, the transactions run from 2016-01-04 to 2026-06-03, with EUR 0 in purchases and EUR 251646 in sales; the most common transaction nature is Levée d'options.
